Dysgeusia Clinical Trial
Official title:
Effects of Flavor Modification for Management of Radiation Induced Dysgeusia in Head and Neck Cancer Patients
Intervention for dysgeusia in head and neck cancer patients undergoing radiation therapy. This research proposal aims to investigate potential benefits of mBerry in improving quality of life and nutritional outcome in head and neck cancer patients' post-radiation therapy. Our hypothesis is that cancer patients undergoing radiation therapy will benefit from use of miracle berry in treatment of dysgeusia.
Dysgeusia, characterized by altered taste, is a common side effect of radiation used in oropharyngeal cancer treatment. Radiation affects taste buds, leading to issues like loss of appetite, malnutrition, dependence on feeding tubes, dysphagia, and impacts social and overall quality of life. Patients often report bitter, metallic or no taste with food after radiation. Miracle berries, known for interacting with sweet taste receptors, could potentially transform acidic tastes into sweet ones. The aim is to explore mBerry's potential in alleviating dysgeusia, aiding patients in achieving better nutritional status and quality of life.This study includes the use of mBerry tablets, which contain protein within the miracle berry called miraculin, for the treatment of radiation-induced dysgeusia. mBerry is not approved by the Food and Drug Administration (FDA) for the treatment of radiation-induced dysgeusia. It is being used as part of this research study to find out if mBerry tablets improve taste outcomes among head and neck cancer patients after radiation therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
| Completed |
NCT01097915 -
Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste
|
||
| Recruiting |
NCT03210441 -
Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer
|
N/A | |
| Completed |
NCT00036881 -
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
|
Phase 3 | |
| Recruiting |
NCT04791436 -
Oral and Olfactory Complications of Recovered COVID-19 Patients
|
||
| Recruiting |
NCT04384042 -
Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
|
||
| Completed |
NCT04390165 -
Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study
|
||
| Completed |
NCT05868850 -
Application of Auricular Point Sticking in Patients With Taste Alteration
|
N/A | |
| Recruiting |
NCT05486260 -
Effect of Dried Miracle Berry on the Olfactory-gustative Perception in Malnourished Cancer Patients
|
N/A | |
| Withdrawn |
NCT05760079 -
Lactoferrin for COVID-19-Induced Taste or Smell Abnormality
|
N/A | |
| Completed |
NCT04473157 -
COVID-19 in Patients With Anosmia in Egypt
|
||
| Recruiting |
NCT02304913 -
Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy
|
N/A | |
| Completed |
NCT01596634 -
Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy
|
N/A | |
| Completed |
NCT04543175 -
Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.
|
||
| Completed |
NCT01540045 -
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
|
||
| Completed |
NCT04629560 -
Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy
|
Early Phase 1 | |
| Recruiting |
NCT02475928 -
Zinc Supplementation in Cirrhotic Patients
|
N/A |